<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MAGNESIUM HYDROXIDE <img border="0" src="../images/pr.gif"/></span><br/>(mag-nes'i-um)<br/><span class="topboxtradename">Magnesia, </span><span class="topboxtradename">Magnesia Magma, </span><span class="topboxtradename">Milk of Magnesia, </span><span class="topboxtradename">M.O.M.<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">saline cathartic</span>; <span class="classification">antacid</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p> 311 mg tablets; 400 mg/5 mL, 800 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Aqueous suspension of magnesium hydroxide with rapid and long-acting neutralizing action. May cause slight acid rebound.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Acts as antacid in low doses and as mild saline laxative at higher doses. Causes osmotic retention of fluid which distends
         colon, resulting in mechanical stimulation of peristaltic activity.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Short-term treatment of occasional constipation, for relief of GI symptoms associated with hyperacidity, and as adjunct in
         treatment of peptic ulcer. Also has been used in treatment of poisoning by mineral acids and arsenic, and as mouthwash to
         neutralize acidity.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Abdominal pain, nausea, vomiting, diarrhea, severe kidney dysfunction, fecal impaction, intestinal obstruction or perforation,
         rectal bleeding, colostomy, ileostomy, lactation. Safety during pregnancy (category B) and in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Laxative</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2.44.8 g (3060 mL)/d in 1 or more divided doses<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>25 y,</i> 0.41.2 g (515 mL)/d in 1 or more divided doses; <i>611 y,</i> 1.22.4 g (1530 mL)/d in 1 or more divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Shake bottle well before pouring to assure mixing of suspension.</li>
<li>Follow drug with at least a full glass of water to enhance drug action for laxative effect. Administer in the morning or at
            bedtime. Most effective when taken on an empty stomach.
         </li>
<li>Store at 15°30° C (59°86° F) in tightly covered container. Slowly absorbs carbon dioxide on
            exposure to air. Avoid freezing.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">GI:</span> Nausea, vomiting, abdominal cramps, <span class="speceff-common">diarrhea</span>. <span class="typehead">Urogenital:</span> Alkalinization of urine. <span class="typehead">Body as a Whole:</span> Weakness, lethargy, mental depression, hyporeflexia, dehydration, <span class="speceff-life">coma</span>. <span class="typehead">Metabolic:</span>  Electrolyte imbalance with prolonged use. <span class="typehead">CV:</span> Hypotension, bradycardia, <span class="speceff-life">complete heart block</span> and <span class="speceff-life">other ECG abnormalities.</span>
<span class="typehead">Respiratory:</span>
<span class="speceff-life">Respiratory depression.</span>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Milk of Magnesia decreases absorption of <b>chlordiazepoxide,</b>
<b>dicumarol,</b>
<b>digoxin,</b>
<b>isoniazid,</b>
<span class="classification">quinolones</span>, <span class="classification">tetracyclines</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 1530% of magnesium is absorbed. <span class="typehead">Onset:</span> 36 h. <span class="typehead">Distribution:</span> Small amounts of magnesium distributed in saliva and breast milk. <span class="typehead">Elimination:</span> Excreted in feces; some renal excretion. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Evaluate the patient's continued need for drug. Prolonged and frequent use of laxative doses may lead to dependence. Additionally,
            even therapeutic doses can raise urinary pH and thereby predispose susceptible patients to urinary infection and urolithiasis.
         </li>
<li>Lab tests: Monitor serum magnesium with signs of hypermagnesemia such as bradycardia (see Appendix F), especially with frequent
            use or any degree of renal impairment.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Investigate the cause of persistent or recurrent constipation or gastric distress with physician.</li>
<li>Do not breast feed while using this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>